VOLT-AF IDE Clinical Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 392 participants.

Also called NCT06223789

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 392 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06223789
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Australia, Austria, Belgium, Canada, Czechia, France, Italy, Netherlands, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06223789. Allocation not applicable; no masking; primary purpose treatment. Start 2024-04-03 (actual); primary completion 2025-10-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
VOLT-AF IDE Clinical Study
Condition
Atrial Arrhythmia
Condition
Paroxysmal Atrial Fibrillation
Condition
Persistent Atrial Fibrillation
Intervention (Device)
Pulsed Field Ablation
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct06223789
Content hash
9ffe00c0a50ef0456fa21bde8200666bb617ab0dc2343dbeb12dde4d369cef3a